Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
TikTok Fined in Europe for Failing to Protect Children
TikTok Fined in Europe for Failing to Protect Children
Stretching Your Dollar: What to Know About Investing in an IPO
What to know about IPOs as a retail investor.
Stretching Your Dollar: Understanding Financial Compatibility
Understanding financial compatibility and finding your match.
Stretching Your Dollar: What the UAW Strike Means for Car Buyers
What the UAW strike means for consumers.
Stretching Your Dollar: Getting More Women Involved in Trade Jobs
Celebrating National Tradesmen Day
Walt Disney Says Not in Talks to Sell ABC
Walt Disney said it was not in any active discussions over the potential sale of ABC.
DoorDash to Move From NYSE to Nasdaq
DoorDash to Move From NYSE to Nasdaq
Writers, Studios May Start Negotiating Again Next Week
Striking Hollywood writers and studios could begin negotiating again next week.
Disney Says It's Not in Active Talks to Sell ABC
Walt Disney Co. said it's not in active talks to sell ABC.
